lenacapavir
Trial Shows Lenacapavir + bNAbs As Possible HIV Treatment
New longer-acting treatment options for HIV may be on the horizon.
JULY 28, 2025
Yeztugo Found Effective, Safe as PrEP in Pregnancy and Lactation
Lenacapavir is safe and effective in individuals who are pregnant and breastfeeding, according to new data ...
JULY 17, 2025
New WHO HIV Guidelines Recommend Lenacapavir for PrEP, Rapid HIV Tests
Lenacapavir should be one choice available for people to take as PrEP for HIV, according to new guidelines released ...
JULY 14, 2025
Key Takeaways for PrEP, HIV Treatment and Other Infectious Diseases
CROI 2025 highlighted promising therapeutic modalities for HIV treatment and prevention.
JULY 3, 2025
FDA Approves Yeztugo for HIV PrEP Lasting 6 Months
The FDA approved lenacapavir, an injectable HIV-1 capsid inhibitor, to be used as PrEP to reduce the risk of ...
JUNE 18, 2025
Positive Results Announced in Lenacapavir and Bictegravir Trials
Late-breaking clinical data show promising results for products aimed at addressing unmet needs in HIV care, ...
FEBRUARY 25, 2025
FDA Accepts NDA for Twice-Yearly Lenacapavir for HIV PrEP
The FDA accepted the New Drug Application for lenacapavir twice-yearly injectable HIV-1 capsid inhibitor by Gilead ...
FEBRUARY 21, 2025
Twice-Yearly Lenacapavir for PrEP Reduced HIV Infections by 96%
The independent Data Monitoring Committee recommended that Gilead stop the blinded phase of the trial and offer ...
SEPTEMBER 13, 2024
Bictegravir and Lenacapavir an Effective ART Switch for People With HIV
A novel combination of bictegravir and lenacapavir appears highly effective in maintaining viral suppression over ...
JULY 26, 2024
Twice-Yearly Lenacapavir 100% Effective in Preventing HIV Among Cisgender Women
An interim analysis of PURPOSE 1 found twice-yearly lenacapavir was superior to once-daily oral FTC/TDF in ...
JULY 24, 2024
Long-Acting Oral Combo for HIV Maintains Viral Suppression at Week 24
Most patients with HIV taking the investigational combination of islatravir (ISL; Merck) plus lenacapavir ...
JUNE 17, 2024
Oral Bridging of Lenacapavir Maintains Viral Suppression Among HIV Patients
Oral bridging of lenacapavir enabled patients to maintain viral suppression of their HIV after missed doses of ...
JULY 26, 2023
